Breast Cancer
‘Disappointing’ data confirm aspirin does not reduce risk for breast cancer relapse
Daily aspirin use did not reduce disease recurrence, progression or mortality in patients with high-risk breast cancer, according to extended follow-up results of a terminated study published in JAMA.
Q&A: Plant-based eating plans for women’s health
Susan Weiner, MS, RDN, CDCES, FADCES, talks with Sharon Palmer, MSFS, RDN, about benefits of plant-based eating plans for women’s health
Increased mortality risk for BRCA carriers diagnosed within 10 years postpartum
Women with breast cancer and germline BRCA pathogenic variants had increased all-cause mortality risk if diagnosis occurred within 10 years postpartum, according to cohort study results published in JAMA Network Open.
Neighborhood disadvantage linked to shorter breast cancer-specific, overall survival
Women with breast cancer living in the most vs. the least disadvantaged neighborhoods had higher risks for breast cancer-specific and overall mortality, according to cohort study results published in JAMA Network Open.
New data ‘offer some hope’ that checkpoint inhibitors may be safe for pregnant women
Use of immune checkpoint inhibitors for pregnant women with cancer may be safer than previously thought, according to study results published in JAMA Network Open.
Pathogenic variants tied to second primary breast cancer diagnosis risk for young survivors
Breast cancer survivors aged 40 years or younger without pathogenic variants had a low second primary breast cancer diagnosis risk in the first 10 years after initial cancer diagnosis, researchers reported in JAMA Oncology.
Cancer surgery reimbursements experience ‘immense’ decline over last 2 decades
The Medicare reimbursement rate for 10 common breast cancer-related surgical operations failed to outpace inflation over the last 20 years, according to a presentation at American Society of Breast Surgeons Annual Meeting.
Health care providers ‘excited’ about convenient, safe OTC birth control pill
In March, the first nonprescription, over-the-counter contraceptive pill became available to buy in stores and online. The progestin-only pill is an important step in boosting access to birth control, according to women’s health providers.
Effects of menopausal hormone therapy vary after age 65 years
Outcomes of using menopausal hormone therapy beyond age 65 years varied based on hormone therapy types, administration and strengths among women on Medicare, researchers reported in Menopause.
Next-generation PARP inhibitor shows clinical benefit in certain patients with breast cancer
Saruparib conferred clinically impactful treatment outcomes among adults with breast cancer who harbor certain genetic mutations, according to data presented at American Association for Cancer Research Annual Meeting.